Français
ItalianoBond Teva Pharmaceutical Finance Netherlands III B.V 6% ( USN8540WAA29 ) in USD
| Issuer | Teva Pharmaceutical Finance Netherlands III B.V |
| Market price | 100 % ▼ |
| Country |  Israel
|
| ISIN code |
 USN8540WAA29 ( in USD )
|
| Interest rate | 6% per year ( payment 2 times a year) |
| Maturity | 14/04/2024 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 1 250 000 000 USD |
| Cusip | N8540WAA2 |
| Standard & Poor's ( S&P ) rating | BB- ( Non-investment grade speculative ) |
| Moody's rating | N/A |
| Detailed description |
Teva Pharmaceutical Finance Netherlands III B.V. is a subsidiary of Teva Pharmaceutical Industries Ltd., a global pharmaceutical company, and functions as a financing vehicle within its broader corporate structure. The Bond issued by Teva Pharmaceutical Finance Netherlands III B.V ( Israel ) , in USD, with the ISIN code USN8540WAA29, pays a coupon of 6% per year. The coupons are paid 2 times per year and the Bond maturity is 14/04/2024 The Bond issued by Teva Pharmaceutical Finance Netherlands III B.V ( Israel ) , in USD, with the ISIN code USN8540WAA29, was rated BB- ( Non-investment grade speculative ) by Standard & Poor's ( S&P ) credit rating agency. |